---
title: "Atricure Still Faces Broad, Evolving Risks Despite No Material Changes in 2025 10-K Disclosures"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294017350.md"
description: "Atricure, Inc. (ATRC) disclosed a new risk under the Regulation category in its 2025 Form 10-K. Despite no material changes to previously outlined risk factors, the company remains exposed to broad risks that could materially impact its business and financial results. Unknown or currently immaterial risks may also emerge. Wall Street maintains a Moderate Buy consensus on ATRC stock, based on five buy ratings and two holds."
datetime: "2026-07-28T06:00:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294017350.md)
  - [en](https://longbridge.com/en/news/294017350.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294017350.md)
generator: "portal-rs"
---

# Atricure Still Faces Broad, Evolving Risks Despite No Material Changes in 2025 10-K Disclosures

Atricure, Inc. (ATRC) has disclosed a new risk, in the Regulation category.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

The analyst notes that Atricure, Inc. remains exposed to the broad set of risks previously outlined in its Form 10-K for the year ended December 31, 2025, any of which could materially impact its business, financial position or future results. He also observes that unknown or currently immaterial risks may still emerge and adversely affect Atricure’s operations, despite no material changes in disclosed risk factors.

Overall, Wall Street has a Moderate Buy consensus rating on ATRC stock based on 5 Buys and 2 Holds.

To learn more about Atricure, Inc.’s risk factors, click here.

### Related Stocks

- [ATRC.US](https://longbridge.com/en/quote/ATRC.US.md)

## Related News & Research

- [BlackRock Inc. Invests $125.20 Million in AtriCure, Inc. $ATRC](https://longbridge.com/en/news/297395019.md)
- [AtriCure CTO Salvatore Privitera sells 7,763 shares worth $407,558](https://longbridge.com/en/news/298032862.md)
- [AtriCure, Inc. $ATRC Shares Sold by Algert Global LLC](https://longbridge.com/en/news/297476951.md)
- [AtriCure (NASDAQ:ATRC) Rating Lowered to "Hold" at Zacks Research](https://longbridge.com/en/news/297043017.md)
- [B. Metzler seel. Sohn & Co. AG Makes New $1.40 Million Investment in AtriCure, Inc. $ATRC](https://longbridge.com/en/news/296750029.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**